The Chernin Group led a $58m Series B round in Equip Health.

The Chernin Group, a multi-stage investment firm, led a $58m Series B round in Equip Health, a health tech company pioneering a program that virtually delivers evidence-based eating disorder treatment to families at home, with participation from Tiger Global, General Catalyst, Katie Couric Media, F-Prime Capital, Optum Ventures, and .406 Ventures. “Treatment for eating disorders is grossly inequitable. Equip’s mission is to ensure that every single person has access to treatment that works. That starts with shifting the conversation around what eating disorders are and who they impact.,” Kristina Saffran Equip Co-Founder and CEO.